Applied statistics in the pharmaceutical industry : with case studies using S-Plus
Author(s)
Bibliographic Information
Applied statistics in the pharmaceutical industry : with case studies using S-Plus
Springer, c2001
Available at 8 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Providing a general guide to statistical methods used in the pharmaceutical industry, and illustrating how to use S-PLUS to implement these methods, the book explains why S-PLUS is a useful software package and discusses the results and implications of each particular application. It is targeted at graduates in biostatistics, statisticians involved in the industry as research scientists, regulators, academics, and/or consultants who want to know more about how to use S-PLUS and learn about other sub-fields within the industry, as well as statisticians in other fields who want to know more about statistical applications in the pharmaceutical industry.
Table of Contents
Statistics and the Drug Development Process, Bruce Rodda and Steven P. Millard * One-Factor Comparative Studies, Bill Pikounis * Analysis of Animal Carcinogenicity Data, Hongshik Ahn and Ralph L. Kodell * Analysis of Toxicokinetic and Pharmacokinetic Data from Animal Studies, Wherly P. Hoffman, Michael A. Heathman, James Z. Chou, and Darrel L. Allen * Analysis of Pharmacokinetic Data, Ha Nguyen and Dhammika Amaratunga * Graphical Presentation of Single Patient Results, Jurgen Bock * Graphical Insight and Data Analysis for the 2, 2, 2, Crossover Design, Bill Pikounis, Tom Bradstreet, and Steven P. Millard * Design and Analysis of Phase I Trials in Clinical Oncology, Axel Benner, Lutz Elder, and Gernot Hartung * Patient Compliance and its Impact on Steady State Pharmacokinetics, Wenping Wang * Analysis of Analgesic Trials, Ene I. Ette, Peter Lockwood, Raymond Miller, and Jaap Mandema * Power and Sample Size Calculations, Jurgen Bock * Comparing Two Treatments in a Large Phase III Clinical Trial, Michaela Jahn * Analysis of Variance: A Comparison Between SAS and S-PLUS, Melvin Olson * Permutation Tests for Phase III Clinical Trials, Vance Berger and Anastasia Ivanova * Sample Size Reestimation, Wenping Wong and Andreas Krause * Meta-Analysis of Clinical Trials, Keith O'Rourke, Beverley Shea, and George A. Wells * Analysis of Health Economic Data, John R. Cook, George W. Carides, and Erik J. Dasbach * Evaluation of the Decimal Reduction Time of a Sterilization Process in Parmaceutical Production, Jeffrey Eisele, Mauro Gasparini, and Amy Racine * Acceptance Sampling Plans by Attributes, Harry Yang and David Carlin
by "Nielsen BookData"